Global Autoimmune Disease Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 128 pages | ID: G679E4C2F94FEN
QYResearch

Abstracts

This report focuses on the global Autoimmune Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autoimmune Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Abbott Laboratories
• Active Biotech
• Eli Lilly
• Bristol-Myers Squibb
• AstraZeneca plc
• Pfizer
• Biogen Idec
• Lupin Limited
• GlaxoSmithKline
• Amgen
• 4SC AG
• F. Hoffmann-La Roche Ltd.
• AutoImmune Inc
• Johnson & Johnson
• Bayer

Market segment by Type, the product can be split into

• Immunosuppressant’s
• Anti-Inflammatory Drugs
• Corticosteroids
• Nonsteroidal anti-inflammatory drugs
• Biologics

Market segment by Application, split into

• Hospitals
• Clinics
• Drug Stores
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Autoimmune Disease Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Autoimmune Disease Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Autoimmune Disease Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Autoimmune Disease Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Autoimmune Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunosuppressant’s
  1.4.3 Anti-Inflammatory Drugs
  1.4.4 Corticosteroids
  1.4.5 Nonsteroidal anti-inflammatory drugs
  1.4.6 Biologics
1.5 Market by Application
  1.5.1 Global Autoimmune Disease Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Drug Stores
  1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Autoimmune Disease Treatment Market Perspective (2015-2026)
2.2 Autoimmune Disease Treatment Growth Trends by Regions
  2.2.1 Autoimmune Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Autoimmune Disease Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Autoimmune Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Autoimmune Disease Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Autoimmune Disease Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Autoimmune Disease Treatment Players by Market Size
  3.1.1 Global Top Autoimmune Disease Treatment Players by Revenue (2015-2020)
  3.1.2 Global Autoimmune Disease Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Autoimmune Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Autoimmune Disease Treatment Market Concentration Ratio
  3.2.1 Global Autoimmune Disease Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Treatment Revenue in 2019
3.3 Autoimmune Disease Treatment Key Players Head office and Area Served
3.4 Key Players Autoimmune Disease Treatment Product Solution and Service
3.5 Date of Enter into Autoimmune Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Autoimmune Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Autoimmune Disease Treatment Forecasted Market Size by Type (2021-2026)

5 AUTOIMMUNE DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Autoimmune Disease Treatment Market Size by Application (2015-2020)
5.2 Global Autoimmune Disease Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Autoimmune Disease Treatment Market Size (2015-2020)
6.2 Autoimmune Disease Treatment Key Players in North America (2019-2020)
6.3 North America Autoimmune Disease Treatment Market Size by Type (2015-2020)
6.4 North America Autoimmune Disease Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Autoimmune Disease Treatment Market Size (2015-2020)
7.2 Autoimmune Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Autoimmune Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Autoimmune Disease Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Autoimmune Disease Treatment Market Size (2015-2020)
8.2 Autoimmune Disease Treatment Key Players in China (2019-2020)
8.3 China Autoimmune Disease Treatment Market Size by Type (2015-2020)
8.4 China Autoimmune Disease Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Autoimmune Disease Treatment Market Size (2015-2020)
9.2 Autoimmune Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Autoimmune Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Autoimmune Disease Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Autoimmune Disease Treatment Market Size (2015-2020)
10.2 Autoimmune Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Autoimmune Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Autoimmune Disease Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Autoimmune Disease Treatment Market Size (2015-2020)
11.2 Autoimmune Disease Treatment Key Players in India (2019-2020)
11.3 India Autoimmune Disease Treatment Market Size by Type (2015-2020)
11.4 India Autoimmune Disease Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Autoimmune Disease Treatment Market Size (2015-2020)
12.2 Autoimmune Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Autoimmune Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Autoimmune Disease Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbott Laboratories
  13.1.1 Abbott Laboratories Company Details
  13.1.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.1.3 Abbott Laboratories Autoimmune Disease Treatment Introduction
  13.1.4 Abbott Laboratories Revenue in Autoimmune Disease Treatment Business (2015-2020))
  13.1.5 Abbott Laboratories Recent Development
13.2 Active Biotech
  13.2.1 Active Biotech Company Details
  13.2.2 Active Biotech Business Overview and Its Total Revenue
  13.2.3 Active Biotech Autoimmune Disease Treatment Introduction
  13.2.4 Active Biotech Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.2.5 Active Biotech Recent Development
13.3 Eli Lilly
  13.3.1 Eli Lilly Company Details
  13.3.2 Eli Lilly Business Overview and Its Total Revenue
  13.3.3 Eli Lilly Autoimmune Disease Treatment Introduction
  13.3.4 Eli Lilly Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.3.5 Eli Lilly Recent Development
13.4 Bristol-Myers Squibb
  13.4.1 Bristol-Myers Squibb Company Details
  13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Introduction
  13.4.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.4.5 Bristol-Myers Squibb Recent Development
13.5 AstraZeneca plc
  13.5.1 AstraZeneca plc Company Details
  13.5.2 AstraZeneca plc Business Overview and Its Total Revenue
  13.5.3 AstraZeneca plc Autoimmune Disease Treatment Introduction
  13.5.4 AstraZeneca plc Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.5.5 AstraZeneca plc Recent Development
13.6 Pfizer
  13.6.1 Pfizer Company Details
  13.6.2 Pfizer Business Overview and Its Total Revenue
  13.6.3 Pfizer Autoimmune Disease Treatment Introduction
  13.6.4 Pfizer Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.6.5 Pfizer Recent Development
13.7 Biogen Idec
  13.7.1 Biogen Idec Company Details
  13.7.2 Biogen Idec Business Overview and Its Total Revenue
  13.7.3 Biogen Idec Autoimmune Disease Treatment Introduction
  13.7.4 Biogen Idec Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.7.5 Biogen Idec Recent Development
13.8 Lupin Limited
  13.8.1 Lupin Limited Company Details
  13.8.2 Lupin Limited Business Overview and Its Total Revenue
  13.8.3 Lupin Limited Autoimmune Disease Treatment Introduction
  13.8.4 Lupin Limited Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.8.5 Lupin Limited Recent Development
13.9 GlaxoSmithKline
  13.9.1 GlaxoSmithKline Company Details
  13.9.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.9.3 GlaxoSmithKline Autoimmune Disease Treatment Introduction
  13.9.4 GlaxoSmithKline Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.9.5 GlaxoSmithKline Recent Development
13.10 Amgen
  13.10.1 Amgen Company Details
  13.10.2 Amgen Business Overview and Its Total Revenue
  13.10.3 Amgen Autoimmune Disease Treatment Introduction
  13.10.4 Amgen Revenue in Autoimmune Disease Treatment Business (2015-2020)
  13.10.5 Amgen Recent Development
13.11 4SC AG
  10.11.1 4SC AG Company Details
  10.11.2 4SC AG Business Overview and Its Total Revenue
  10.11.3 4SC AG Autoimmune Disease Treatment Introduction
  10.11.4 4SC AG Revenue in Autoimmune Disease Treatment Business (2015-2020)
  10.11.5 4SC AG Recent Development
13.12 F. Hoffmann-La Roche Ltd.
  10.12.1 F. Hoffmann-La Roche Ltd. Company Details
  10.12.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  10.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Introduction
  10.12.4 F. Hoffmann-La Roche Ltd. Revenue in Autoimmune Disease Treatment Business (2015-2020)
  10.12.5 F. Hoffmann-La Roche Ltd. Recent Development
13.13 AutoImmune Inc
  10.13.1 AutoImmune Inc Company Details
  10.13.2 AutoImmune Inc Business Overview and Its Total Revenue
  10.13.3 AutoImmune Inc Autoimmune Disease Treatment Introduction
  10.13.4 AutoImmune Inc Revenue in Autoimmune Disease Treatment Business (2015-2020)
  10.13.5 AutoImmune Inc Recent Development
13.14 Johnson & Johnson
  10.14.1 Johnson & Johnson Company Details
  10.14.2 Johnson & Johnson Business Overview and Its Total Revenue
  10.14.3 Johnson & Johnson Autoimmune Disease Treatment Introduction
  10.14.4 Johnson & Johnson Revenue in Autoimmune Disease Treatment Business (2015-2020)
  10.14.5 Johnson & Johnson Recent Development
13.15 Bayer
  10.15.1 Bayer Company Details
  10.15.2 Bayer Business Overview and Its Total Revenue
  10.15.3 Bayer Autoimmune Disease Treatment Introduction
  10.15.4 Bayer Revenue in Autoimmune Disease Treatment Business (2015-2020)
  10.15.5 Bayer Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Autoimmune Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Autoimmune Disease Treatment Revenue
Table 3. Ranking of Global Top Autoimmune Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Autoimmune Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunosuppressant’s
Table 6. Key Players of Anti-Inflammatory Drugs
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Nonsteroidal anti-inflammatory drugs
Table 9. Key Players of Biologics
Table 10. Global Autoimmune Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Autoimmune Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Autoimmune Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Autoimmune Disease Treatment Market Share by Regions (2015-2020)
Table 14. Global Autoimmune Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Autoimmune Disease Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Autoimmune Disease Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Autoimmune Disease Treatment Players
Table 21. Global Autoimmune Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Autoimmune Disease Treatment Market Share by Players (2015-2020)
Table 23. Global Top Autoimmune Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Treatment as of 2019)
Table 24. Global Autoimmune Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Autoimmune Disease Treatment Product Solution and Service
Table 27. Date of Enter into Autoimmune Disease Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Autoimmune Disease Treatment Market Size Share by Type (2015-2020)
Table 31. Global Autoimmune Disease Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Autoimmune Disease Treatment Market Size Share by Application (2015-2020)
Table 33. Global Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Autoimmune Disease Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 37. North America Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 39. North America Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 43. Europe Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 45. Europe Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 49. China Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 51. China Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 55. Japan Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 57. Japan Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 61. Southeast Asia Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 67. India Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 69. India Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Autoimmune Disease Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Autoimmune Disease Treatment Market Share (2019-2020)
Table 73. Central & South America Autoimmune Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Autoimmune Disease Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Autoimmune Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Autoimmune Disease Treatment Market Share by Application (2015-2020)
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Product
Table 80. Abbott Laboratories Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 81. Abbott Laboratories Recent Development
Table 82. Active Biotech Company Details
Table 83. Active Biotech Business Overview
Table 84. Active Biotech Product
Table 85. Active Biotech Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 86. Active Biotech Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Product
Table 90. Eli Lilly Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 91. Eli Lilly Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. AstraZeneca plc Company Details
Table 98. AstraZeneca plc Business Overview
Table 99. AstraZeneca plc Product
Table 100. AstraZeneca plc Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 101. AstraZeneca plc Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Biogen Idec Company Details
Table 108. Biogen Idec Business Overview
Table 109. Biogen Idec Product
Table 110. Biogen Idec Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 111. Biogen Idec Recent Development
Table 112. Lupin Limited Business Overview
Table 113. Lupin Limited Product
Table 114. Lupin Limited Company Details
Table 115. Lupin Limited Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 116. Lupin Limited Recent Development
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Product
Table 120. GlaxoSmithKline Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 121. GlaxoSmithKline Recent Development
Table 122. Amgen Company Details
Table 123. Amgen Business Overview
Table 124. Amgen Product
Table 125. Amgen Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 126. Amgen Recent Development
Table 127. 4SC AG Company Details
Table 128. 4SC AG Business Overview
Table 129. 4SC AG Product
Table 130. 4SC AG Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 131. 4SC AG Recent Development
Table 132. F. Hoffmann-La Roche Ltd. Company Details
Table 133. F. Hoffmann-La Roche Ltd. Business Overview
Table 134. F. Hoffmann-La Roche Ltd. Product
Table 135. F. Hoffmann-La Roche Ltd. Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 136. F. Hoffmann-La Roche Ltd. Recent Development
Table 137. AutoImmune Inc Company Details
Table 138. AutoImmune Inc Business Overview
Table 139. AutoImmune Inc Product
Table 140. AutoImmune Inc Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 141. AutoImmune Inc Recent Development
Table 142. Johnson & Johnson Company Details
Table 143. Johnson & Johnson Business Overview
Table 144. Johnson & Johnson Product
Table 145. Johnson & Johnson Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 146. Johnson & Johnson Recent Development
Table 147. Bayer Company Details
Table 148. Bayer Business Overview
Table 149. Bayer Product
Table 150. Bayer Revenue in Autoimmune Disease Treatment Business (2015-2020) (Million US$)
Table 151. Bayer Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Autoimmune Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressant’s Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Nonsteroidal anti-inflammatory drugs Features
Figure 6. Biologics Features
Figure 7. Global Autoimmune Disease Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Other Case Studies
Figure 12. Autoimmune Disease Treatment Report Years Considered
Figure 13. Global Autoimmune Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Autoimmune Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Autoimmune Disease Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Autoimmune Disease Treatment Market Share by Players in 2019
Figure 18. Global Top Autoimmune Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Disease Treatment Revenue in 2019
Figure 20. North America Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Autoimmune Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 29. Active Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Active Biotech Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 31. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Eli Lilly Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 33. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 35. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 37. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Pfizer Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 39. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Biogen Idec Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 41. Lupin Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Lupin Limited Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 43. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 45. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Amgen Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 47. 4SC AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. 4SC AG Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 49. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 51. AutoImmune Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AutoImmune Inc Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 53. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bayer Revenue Growth Rate in Autoimmune Disease Treatment Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed